NYSE - Nasdaq Real Time Price • USD
Globus Medical, Inc. (GMED)
As of 11:27 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 15 | 15 |
| Avg. Estimate | 0.57 | 0.66 | 2.69 | 3.29 |
| Low Estimate | 0.49 | 0.63 | 2.68 | 3.06 |
| High Estimate | 0.62 | 0.69 | 2.72 | 3.9 |
| Year Ago EPS | 0.53 | 0.63 | 2.32 | 2.69 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 15 | 15 |
| Avg. Estimate | 587.14M | 616.02M | 2.46B | 2.65B |
| Low Estimate | 576.6M | 606.4M | 2.44B | 2.61B |
| High Estimate | 598.49M | 623M | 2.48B | 2.7B |
| Year Ago Sales | 276.69M | 291.62M | 1.57B | 2.46B |
| Sales Growth (year/est) | 112.20% | 111.20% | 57.10% | 7.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.51 | 0.59 | 0.57 | 0.61 |
| EPS Actual | 0.53 | 0.63 | 0.57 | 0.6 |
| Difference | 0.02 | 0.04 | 0 | -0.01 |
| Surprise % | 3.90% | 6.80% | 0.00% | -1.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.57 | 0.66 | 2.69 | 3.29 |
| 7 Days Ago | 0.57 | 0.66 | 2.69 | 3.29 |
| 30 Days Ago | 0.57 | 0.66 | 2.69 | 3.29 |
| 60 Days Ago | 0.57 | 0.66 | 2.69 | 3.29 |
| 90 Days Ago | 0.6 | 0.67 | 2.69 | 3.29 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | GMED | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 7.50% | -- | -- | 1.50% |
| Next Qtr. | 4.80% | -- | -- | 11.40% |
| Current Year | 15.90% | -- | -- | 5.20% |
| Next Year | 22.30% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 16.20% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 13.13% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | BTIG: Neutral to Buy | 3/18/2024 |
| Maintains | Stifel: Buy to Buy | 2/21/2024 |
| Maintains | Truist Securities: Hold to Hold | 2/21/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/11/2024 |
| Maintains | Truist Securities: Hold to Hold | 12/22/2023 |
| Maintains | Canaccord Genuity: Buy to Buy | 12/20/2023 |
Related Tickers
ATEC Alphatec Holdings, Inc.
12.35
-3.06%
OFIX Orthofix Medical Inc.
13.02
-3.98%
MASI Masimo Corporation
133.91
-1.48%
FNA Paragon 28, Inc.
9.27
-3.84%
ZBH Zimmer Biomet Holdings, Inc.
119.21
-1.62%
NARI Inari Medical, Inc.
38.14
-0.10%
IRTC iRhythm Technologies, Inc.
112.58
-3.31%
TMCI Treace Medical Concepts, Inc.
10.36
-2.91%
CNMD CONMED Corporation
63.67
-9.06%
NVCR NovoCure Limited
12.03
-2.51%